Yi Tu

638 total citations
24 papers, 440 citations indexed

About

Yi Tu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yi Tu has authored 24 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Yi Tu's work include MicroRNA in disease regulation (5 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). Yi Tu is often cited by papers focused on MicroRNA in disease regulation (5 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). Yi Tu collaborates with scholars based in China, South Korea and United States. Yi Tu's co-authors include Yi Cao, Zhengrong Li, Feng Yao, Zhigang Jie, Chuang Chen, Shan Xu, Yi Liu, Guoming Zhu, Sung Soo Park and Zhigang Jie and has published in prestigious journals such as Advanced Science, Cancer Letters and Medicine.

In The Last Decade

Yi Tu

22 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Tu China 11 237 195 156 49 44 24 440
Feng Yao China 12 204 0.9× 183 0.9× 178 1.1× 49 1.0× 23 0.5× 22 468
Yisheng Tao China 13 275 1.2× 149 0.8× 158 1.0× 28 0.6× 112 2.5× 32 506
Aurore Toullec France 10 219 0.9× 144 0.7× 168 1.1× 42 0.9× 52 1.2× 15 513
Huangang Jiang China 10 172 0.7× 115 0.6× 108 0.7× 36 0.7× 51 1.2× 16 334
Pei‐Ju Lien Taiwan 9 158 0.7× 61 0.3× 81 0.5× 35 0.7× 35 0.8× 33 367
Nadeem Bilani United States 10 82 0.3× 105 0.5× 161 1.0× 18 0.4× 74 1.7× 38 364
Philipp Baumann Switzerland 9 243 1.0× 51 0.3× 113 0.7× 34 0.7× 34 0.8× 17 436
Lijie Zhu China 13 264 1.1× 101 0.5× 54 0.3× 21 0.4× 97 2.2× 48 483
Haojun Yang China 13 199 0.8× 92 0.5× 73 0.5× 18 0.4× 54 1.2× 38 380

Countries citing papers authored by Yi Tu

Since Specialization
Citations

This map shows the geographic impact of Yi Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Tu more than expected).

Fields of papers citing papers by Yi Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Tu. The network helps show where Yi Tu may publish in the future.

Co-authorship network of co-authors of Yi Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Tu. A scholar is included among the top collaborators of Yi Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Tu. Yi Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jie, Yi Tu, Shan Zhang, et al.. (2025). Gigaxonin Potentiates Antiviral Innate Immune Responses by Targeting cGAS and TREX1. Advanced Science. 12(44). e07146–e07146.
2.
3.
Fang, Kang, Xiaowei Fu, Long Peng, et al.. (2023). Solid Pseudopapillary Neoplasm of the Pancreas. Pancreas. 52(2). e121–e126. 4 indexed citations
4.
Wu, Yukang, Yi Cao, Jianbo Xiong, et al.. (2022). Comprehensive Analysis of Immune Infiltrates of Ferroptosis-Related Long Noncoding RNA and Prediction of Colon Cancer Patient Prognoses. Journal of Immunology Research. 2022. 1–16. 24 indexed citations
5.
Hong, Junbo, Wei Zuo, Anjiang Wang, et al.. (2022). Potential Factors Predicting Histopathologically Upgrade Discrepancies between Endoscopic Forceps Biopsy of the Colorectal Low‐Grade Intraepithelial Neoplasia and Endoscopic Resection Specimens. BioMed Research International. 2022(1). 1915458–1915458. 2 indexed citations
6.
7.
Zhang, Yang, et al.. (2022). Role of STX6 as a prognostic factor associated with immune infiltration in hepatocellular carcinoma. Oncology Letters. 24(4). 371–371. 4 indexed citations
8.
Li, Juanjuan, Cesar Augusto Santa-Maria, Pengcheng Zhang, et al.. (2020). Patient-reported Outcomes of Patients With Breast Cancer During the COVID-19 Outbreak in the Epicenter of China: A Cross-sectional Survey Study. Clinical Breast Cancer. 20(5). e651–e662. 94 indexed citations
9.
Fu, Xiaowei, Le Van Hong, Yi Tu, et al.. (2020). MicroRNA‐148a‐3p suppresses epithelial‐to‐mesenchymal transition and stemness properties via Wnt1‐mediated Wnt/β‐catenin pathway in pancreatic cancer. Journal of Cellular and Molecular Medicine. 24(22). 13020–13035. 17 indexed citations
10.
Xiong, Jianbo, Yi Tu, Daojiang Li, et al.. (2019). <p>Epigenetics mechanisms mediate the miR-125a/BRMS1 axis to regulate invasion and metastasis in gastric cancer</p>. OncoTargets and Therapy. Volume 12. 7513–7525. 7 indexed citations
11.
Xiong, Jianbo, Zhengrong Li, Tao Zhong, et al.. (2019). Overexpression of TWA1 predicts poor prognosis in patients with gastric cancer. Pathology - Research and Practice. 215(11). 152594–152594. 7 indexed citations
12.
Cao, Yi, Jianbo Xiong, Zhengrong Li, et al.. (2019). CENPO expression regulates gastric cancer cell proliferation and is associated with poor patient prognosis. Molecular Medicine Reports. 20(4). 3661–3670. 13 indexed citations
13.
Xiong, Yifeng, Lizhen Wang, Shanshan Wang, et al.. (2019). Downregulation of miR‑186 promotes the proliferation and drug resistance of glioblastoma cells by targeting Twist1. Molecular Medicine Reports. 19(6). 5301–5308. 12 indexed citations
14.
Wang, Shanshan, Xuan Liu, Weijia Wang, et al.. (2018). The Effects of Silencing the Her2 Gene on Proliferation and Angiogenesis of Meningioma Cells in vivo and in vitro.. PubMed. 48(5). 580–586. 3 indexed citations
15.
Cao, Yi, Yi Tu, Guoyang Zhang, et al.. (2018). MicroRNA‑125a‑5p inhibits invasion and metastasis of gastric cancer cells by targeting BRMS1 expression. Oncology Letters. 15(4). 5119–5130. 34 indexed citations
16.
Wang, Zhaoyin, Weijia Wang, Shan Xu, et al.. (2016). The role of MAPK signaling pathway in the Her-2-positive meningiomas. Oncology Reports. 36(2). 685–695. 26 indexed citations
17.
Chen, Chuang, Si Sun, Jingping Yuan, et al.. (2016). Characteristics of breast cancer in Central China, literature review and comparison with USA. The Breast. 30. 208–213. 42 indexed citations
18.
Wang, Weijia, Yi Tu, Shanshan Wang, et al.. (2015). Role of HER-2 activity in the regulation of malignant meningioma cell proliferation and motility. Molecular Medicine Reports. 12(3). 3575–3582. 12 indexed citations
19.
Cao, Yi, Yi Tu, Zhengrong Li, et al.. (2013). RNAi-mediated knockdown of PRL-3 inhibits cell invasion and downregulates ERK 1/2 expression in the human gastric cancer cell line, SGC-7901. Molecular Medicine Reports. 7(6). 1805–1811. 8 indexed citations
20.
Li, Zhengrong, Yi Cao, Zhigang Jie, et al.. (2012). miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3. Cancer Letters. 323(1). 41–47. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feng Yao Breakdown of academic impact, for papers by Yisheng Tao Breakdown of academic impact, for papers by Aurore Toullec Breakdown of academic impact, for papers by Huangang Jiang Breakdown of academic impact, for papers by Pei‐Ju Lien Breakdown of academic impact, for papers by Nadeem Bilani Breakdown of academic impact, for papers by Philipp Baumann Breakdown of academic impact, for papers by Lijie Zhu Breakdown of academic impact, for papers by Haojun Yang
Rankless by CCL
2026